Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 7NX57 | IM / RA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | J4K4X | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 3 | Y1A212M | IM / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | AH7Z3 | IM / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z008196 | SC / RA |
Patient was sitting down in chair and receiving vaccines at approximately 10:30. After 5th vaccine out of 8 scheduled patient began feeling lightheaded, dizzy, and reported blurry vision. Patient became pale and sweaty and was conscious but not responding for several minutes. Vital signs were taking starting at 10:35 and were: B/P: 70/39, HR: 48, O2: 97%. Then at 10:40 B/P: 113/75, HR: 66, O2: 95%. At 10:45 B/P: 111/70, HR: 60, O2: 96%. And at 10:50 the final set of vitals were: B/P: 113/73, HR: 54, O2: 97%, Temp: 97.6 F, and Blood Glucose: 122 after giving patient orange juice. Patient was evaluated by EMS and deemed stable. Parent declined going to hospital. Patient was stable and able to walk out of clinic today.
None
NKA/NKDA